Edition:
India

Zimmer Biomet Holdings Inc (ZBH.N)

ZBH.N on New York Stock Exchange

114.89USD
13 Jul 2018
Change (% chg)

$0.85 (+0.75%)
Prev Close
$114.04
Open
$114.13
Day's High
$115.00
Day's Low
$113.60
Volume
148,113
Avg. Vol
273,700
52-wk High
$133.45
52-wk Low
$104.28

Chart for

About

Zimmer Biomet Holdings, Inc. is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company's products... (more)

Overall

Beta: 1.18
Market Cap(Mil.): $24,115.91
Shares Outstanding(Mil.): 202.20
Dividend: 0.24
Yield (%): 0.80

Financials

BRIEF-Zimmer Biomet Reports Q1 Earnings Per Share $0.85

* ZIMMER BIOMET ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS

26 Apr 2018

BRIEF-Zimmer Biomet Announces FDA Clearance And First Surgical Case Of The Persona Trabecular Metal Tibia

* ZIMMER BIOMET ANNOUNCES FDA CLEARANCE AND FIRST SURGICAL CASE OF THE PERSONA® TRABECULAR METAL™ TIBIA

17 Apr 2018

BRIEF-Zimmer Biomet Says CEO Hanson's FY'17 Total Compensation Was $16.3 Mln

* ZIMMER BIOMET SAYS CEO BRYAN HANSON'S FY 2017 TOTAL COMPENSATION WAS $16.3 MLN - SEC FILING

03 Apr 2018

BRIEF-Zimmer Biomet Holdings Files For Offering Of Floating Rate Notes Due 2021

* ZIMMER BIOMET HOLDINGS INC - FILES FOR OFFERING OF FLOATING RATE NOTES DUE 2021 AND NOTES DUE 2023 - SEC FILING Source text: (http://bit.ly/2tzlxYD) Further company coverage:

08 Mar 2018

BRIEF-Zimmer Biomet Holdings Reports Q4 EPS Of $6.16

* ZIMMER BIOMET ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2017 RESULTS

30 Jan 2018

Competitors

Earnings vs. Estimates